This downturn is different.

Youssef Sebban interview by Carol Massar and Tim Stenovec on Bloomberg Businessweek.
Listen NowInsights, news, commentary and interviews about the life sciences, healthcare and tech world.
Covering life science innovation, market analysis and investment strategy.
Our views on the economy and where the markets are headed next; which sectors (and sub-sectors) to invest in and which markets to avoid.
We believe that the “impending” recession is counterbalanced with strong economic data and once we start to peel the layers, we see a slightly different picture.
Read the WhitepaperInvesting In Early-Stage Healthcare Companies
Looks at what’s been driving the record investment into healthcare, what to look for and why commercialization is key.
Read ReportThe Future of Wearable Healthtech.
Reviews the innovation drivers and the dramatic growth potential of this very significant market.
Read the ReportYoussef Sebban interview by Carol Massar and Tim Stenovec on Bloomberg Businessweek.
Listen NowImproving protein therapeutics through anti-glycation modification.
Watch the podcastOur views on the economy and where the markets are headed next; which sectors (and sub-sectors) to invest in and which markets to avoid.
Read ReportWhere is Big Pharma placing its bets? The upcoming ~$200B patent cliff and the stormy market conditions have significantly increased the pressure on Big Pharma to sustain pipelines while controlling costs. Most of the industry majors slashed their R&D budgets in 2022.
Read ReportThe era of investing in unproven bets is gone, for the foreseeable future, and only the truly innovative and commercially minded will survive.
Read the articleThe Future of Wearable HealthTech
Reviews the innovation drivers and the dramatic growth potential of this very significant market.
Read ReportThe “impending” recession is counterbalanced with strong economic data and once we start to peel the layers a different picture emerges.
Read the ArticleInvesting in a promising early-stage healthcare company.
Commercialization is key.
Read the article.Alléger les coûts de la bioproduction
Reducing the costs of biologic manufacturing. (In french)
Read the article.Bloomberg Businessweek. Carol Massar and Tim Stenovec interview Youssef Sebban. May 31, 2022
Listen to the interview.